TITLE

The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010

AUTHOR(S)
Yongdi Chen; Huakun Lv; Hua Gu; Fujiang Cui; Fuzhen Wang; Jun Yao; Shichang Xia; Xiaofeng Liang
PUB. DATE
February 2014
SOURCE
Human Vaccines & Immunotherapeutics;Feb2014, Vol. 10 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
94752443

 

Related Articles

  • The importance of a preschool booster for children born to hepatitis B-positive mothers. Ladhani, Shamez N.; Ramsay, Mary E. // Archives of Disease in Childhood;Jun2013, Vol. 98 Issue 6, p395 

    The author focuses on the chronic hepatitis B virus (HBV) infection which is associated with cirrhosis, hapatic failure and hepatocellular carcinoma. He reports that the World Health Organization (WHO) has recommended the childhood hepatitis B immunization at birth. He mentions about the...

  • Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran. Yazdanpanah, Behrouz; Safari, Mitra; Yazdanpanah, Shahrzad // Hepatitis Monthly;Winter2010, Vol. 10 Issue 1, p17 

    Background and Aims: The duration of the protection of hepatitis B vaccination for infants and the necessity of a booster dose administration is unknown. The aim of the present study was to evaluate the persistence of seroprotection after hepatitis B virus (HBV) vaccination in order to determine...

  • Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization. Edelman, K.; Malmström, K.; He, Q.; Savolainen, J.; Terho, E. O.; Mertsola, J.; Malmström, K // European Journal of Pediatrics;1999, Vol. 158 Issue 12, p989 

    Local reactions and pertussis toxin specific immunoglobulin E antibodies (PT-IgE) were investigated in healthy children following primary and booster immunization with a combined diphtheria tetanus acellular pertussis vaccine (DTPa) including pertussis toxin, filamentous haemagglutinin and...

  • A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. Giambi, Cristina; Bella, Antonino; Barale, Antonella; Montù, Domenico; Marchisio, Maria; Oddone, Maurizio; Zito, Salvatore; Rapicetta, Maria; Chionne, Paola; Madonna, Elisabetta; Ciofi degli Atti, Marta L. // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: In 2001, two hexavalent vaccines were licensed in Italy (Hexavac®, Infanrix Hexa®), and since 2002 were extensively used for primary immunization in the first year of life (at 3, 5, 11/12 months of age). In 2005, the market authorization of Hexavac® was precautionary...

  • Hepatitis A Vaccine. Bader, Teddy F. // American Journal of Gastroenterology;Feb1996, Vol. 91 Issue 2, p217 

    Hepatitis A continues to cause sporadic cases, epidemics, and occasional deaths in the United States. A killed virus vaccine for immunization against hepatitis A has recently been approved by the Food and Drug Administration. One hundred percent seroconversion occurs after a series consisting of...

  • The necessity of booster vaccination after neonatal hepatitis B vaccination. Lankarani, Kamran Bagheri // Hepatitis Monthly;Jun2011, Vol. 11 Issue 6, p419 

    The author reflects on the necessity to implement a boost or advancement in the vaccination for neonatal hepatitis B virus (HBV). The author states that the booster vaccination for HBV lies on impact of antibody level reduction in immunity system and on the certainty for HBV recurrence in...

  • BOOSTER SHOTS NOT NEEDED.  // AIDS Patient Care & STDs;May2000, Vol. 14 Issue 5, p285 

    Presents research findings suggesting that booster doses of hepatitis B vaccine are not needed in immunocompromised patients who respond to a primary course of immunization. Duration of protection afforded by the booster doses; Health conditions of individuals needing the booster shots.

  • Hepatitis B Immunity and Response to Booster Vaccination in Children With Inflammatory Bowel Disease Treated With Infliximab. Moses, Jonathan; Alkhouri, Naim; Shannon, Angela; Raig, Kathy; Lopez, Rocio; Danziger-Isakov, Lara; Feldstein, Ariel E; Zein, Nizar N; Wyllie, Robert; Carter-Kent, Christine // American Journal of Gastroenterology;Jan2012, Vol. 107 Issue 1, p133 

    OBJECTIVES:Hepatitis B virus (HBV) reactivation has been described in patients treated with infliximab for inflammatory bowel disease (IBD). This has resulted in a 'black box' warning. Although universal vaccination against hepatitis B was implemented in the United States in 1991, up to 10% of...

  • DTPa-HBV-IPV/Hib Vaccine (Infanrix hexaâ„¢). Curran, Monique P.; Goa, Karen L. // Drugs;2003, Vol. 63 Issue 7, p673 

    â–´ Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B recombinant (adsorbed)-inactivated poliomyelitis-adsorbed conjugated Haemophilus influenzae type b vaccine (DTPa-HBV-IPV/Hib; Infanrix hexaâ„¢) provided high levels of seroprotection against...

  • Vaccination and prophylaxis against hepatitis B in children.  // American Family Physician;10/1/1994, Vol. 50 Issue 5, p979 

    Discusses the prevention of hepatitis B infection in children. Immunization; Prophylaxis; Vaccine types; Schedule; Dosage and administration; Precautions; Adverse reactions.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics